• Miscellaneous dermatological conditions

Latisse Generic Name & Formulations

General Description

Bimatoprost 0.03%; oph soln; contains benzalkonium chloride.

Pharmacological Class

Prostaglandin analogue.

How Supplied

Soln—3mL, 5mL (w. disposable sterile applicators)


Generic Availability


Latisse Indications


Hypotrichosis of the eyelashes.

Latisse Dosage and Administration


1 drop once nightly; apply evenly along upper eyelid skin margin at the base of eyelashes. Repeat for opposite eyelid margin with new sterile applicator. Blot any excess solution runoff.


Not recommended.

Latisse Contraindications

Not Applicable

Latisse Boxed Warnings

Not Applicable

Latisse Warnings/Precautions


Do not apply to lower eyelash line. Repeated contact with bimatoprost outside the treatment area may cause hair growth. Ocular hypertension; monitor for changes to intraocular pressure. Intraocular inflammation (eg, uveitis). Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Contact lenses (remove; may reinsert lenses 15 mins after administration). Pregnancy. Nursing mothers.

Latisse Pharmacokinetics

See Literature

Latisse Interactions


Concomitant with other intraocular pressure (IOP)-lowering prostaglandin analogues may decrease IOP-lowering effects.

Latisse Adverse Reactions

Adverse Reactions

Eye pruritus, conjunctival hyperemia, skin pigmentation, ocular irritation, dry eye symptoms, periorbital erythema, foreign body sensation, abnormal hair growth, iris hyperpigmentation, others.

Latisse Clinical Trials

See Literature

Latisse Note

Not Applicable

Latisse Patient Counseling

See Literature